Randox Laboratories Limited is founded by Dr Peter FitzGerald in April 1982
Reagents in the early years
Consisted of AST, ALT, ALP, CK-NAC, Gamma GT, LDH and HBDH, all of which are still produced today
Northern Ireland Institute of Export Award
Exporter of the Year Award
Royal visit from HRH Princess Anne
Visit from Northern Ireland Government Minister for Economic Development
Northern Ireland Institute of Export Award
SMART Award
Northern Ireland Export Award
Export Award for Smaller Businesses
National Westminster Bank/DTI Travel Award for Shop Floor Worker
Visit to a now long-standing customer in Syria, the first of many international visits
National Westminster Bank/DTI Travel Award for Shop Floor Worker
Better Made in Britain Award
SMART Award
1st Queen’s Award for Export Achievement
European Business of the Year Award
Gallagher Business Challenge Award
Opening of our first international office, in France
Business in Europe Awards
Opening of office in Portugal
2nd Queen’s Award for Export Achievement
Began exporting to China, the world’s second largest economy
Opening of office in Canada
Visit to Iraq secured another of our now many international partners. Today we still supply products to Iraq
Opening of office in Germany
Accredited to ISO 9002
SMART Award
3rd Queen’s Award for Export Achievement
Awarded our first patent for biochip
Mrs FitzGerald is awarded the Order of the British Empire (OBE), for services to business in Northern Ireland
Opening of offices in Slovakia, Czech Republic, Spain and the United States of America
Opening of offices in Poland and Puerto Rico
Opening of office in Kyrgyzstan
Northern Ireland Business Award for International Trade
We extended our headquarters to facilitate increasing manufacturing demands
Accredited to ISO 9001
4th Queen’s Award for Enterprise
Launch of the first biochip analyser, Evidence
Completion of the development of Biochip Array Technology
Opening of office in China
RIQAS accredited with UKAS approval, the International accreditation for the provision of proficiency testing programmes
Launch of our first clinical chemistry analyser, RX daytona
Royal Academy of Engineering MacRobert Award for the Evidence analyser
The Evidence analyser was displayed for a year in the London Science museum after winning the prestigious MacRobert Award
Accredited to ISO 13485
Launch of Acusera 24-7 Internal Quality Control (IQC) peer group reporting package
Royal Academy of Engineering MacRobert Award for the Evidence analyser
Launch of the second biochip analyser, Evidence Investigator
Ernst & Young Entrepreneur of The Year 2004
Launch of the second clinical chemistry analyser, RX imola
Launch of the third clinical chemistry analysers, RX monza
Confederation of British Industry Growing Business Award
Chartered Institute of Marketing Award
Chamber of Commerce Regional Award
Chamber of Commerce Regional Award
Frost & Sullivan European Technology Innovation of the Year Award
Northern Ireland International Trade Award
5th Queen’s Award for Enterprise International Trade award
The opening of our site in Dungloe, County Donegal for analyser manufacture and Research & Development
Belfast Telegraph Northern Ireland Business Awards
Launch of the third biochip analyser, Evidence MultiStat which was designed to bring testing to the bedside or site of patient care
UTV Business Personality of the Year Award - Dr Peter FitzGerald outright winner
South Antrim Business Awards
Manufacturing Excellence Awards
Invest NI Innovation & Export Awards
We were honoured with a second Royal visit by HRH Prince Andrew
Total re-branding programme to Randox corporate identity incorporating a red dot symbolising a drop of blood
Launch of the fourth biochip analyser, Evidence Evolution
International Trade Company of the Year Award
Exporting Achievement Award
Opening of a new facility in West Virginia, USA to expand our manufacturing and distribution capabilities
Randox Health Checks Limited was launched in Northern Ireland bringing health screening to the public
Marketing Excellence Award: Manufacturing Sector
Dr Peter FitzGerald is appointed as Commander of the Order of the British Empire (CBE), for services to business in Northern Ireland
Launch of the fourth clinical chemistry analyser, RX suzuka
Opening of a 30,000 square feet facility in Bangalore, India
Launch of two new companies
Randox Health Checks opens in the centre of London
Randoc Health open a state of the art facility to provide a top class testing service which offers a comprehensive picture of health
Launch of the fifth clinical chemistry analyser, RX daytona plus
Randox Biosciences Created
Randox invests £15 million in R&D ‘Roadmap’ to target the international personalised medicine market
Randox unveils new weapon in fight against Flakka
Randox create the World’s first test for Flakka
Randox unveils Evidence MultiSTAT Analyser
Randox launches the fully automated immunoanalyser which enables on-site simultaneous detection of up to 44 analytes from a single sample
ApoE4 test produced which detects Alzheimer’s risk in 3 hours
Randox Science Park
£161m investment including £29m capital project and creation of 540 jobs
Randox announced as headline sponsor of Randox Health Grand National
Randox announce a 5 year partnership with the world’s greatest race,
Randox announces that from its inception in 1982 the global healthcare company has now surpassed £1 billion of total sales in medical diagnostic products, cementing itself as a global market leader in diagnostic goods.
Official opening of Randox Health Holywood Clinic
Partnership with Dana-Farber Cancer Institute Announced
Randox Biosciences and Dana-Farber Cancer Institute celebrate success of Transatlantic Partnership in extensive research into life sciences.
£7m Biomedical Engineering Laboratory with Ulster University
Antimicrobial Array I receives AOAC Certification
European partnership with French biotech company Transgene, which aims to develop a game-changing therapy for cancer treatments
‘Anti-cancer weapons’ developed in innovative partnership between Randox and Transgene
Randox Food Diagnostics unveil Infiniplex for Milk
£50m Centres of Excellence launched with Invest NI
A record £50 million investment which will deliver cutting-edge technologies to diagnose several conditions in collaboration with invest NI
Randox announces strategic partnership with Qnostics
£5m Industrial PhD Academy with ulster University
Official opening of Randox Health Liverpool
Randox innovations showcased at Goodwood Future Lab
Current and futuristic developments showcased at Goodwood displaying how current and future critical health risks can be identified through detailed analysis of blood
Dr FitzGerald named as Irish Times Business Person of the Month
Dr FitzGerald receives Business Relations Award from Ireland-US Council
Randox and Ulster University team up for major student sports sponsorship deal
The investment from Randox will supply kit and equipment for 70 sports clubs across the university’s four campuses, including individual and team sports such as basketball, GAA, hockey, football, athletics and more. As of 2021, 5000 students have taken part in sports club activities and more than 3000 students have worn a Randox jersey.
New test developed for accurate differentiation of stroke types
The ground-breaking new test which has a unique ability to differentiate between ischaemic and haemorrhagic stroke, the Randox Stroke Biochip takes less than 30 minutes to complete – making sure patients get the right diagnosis as fast as possible.
RX Daytona+ achieves FDA 510K clearance
Randox Food named as Top 10 European Food and Beverage Technology Solution Provider
Randox playing integral role in UK Government’s national COVID-19 testing programme
Randox are playing a leading role within the fight against the COVID-19 global pandemic, as an integral part of the national testing programme Randox have invested £30m in a new COVID-19 testing laboratory at the Randox Science Park in Northern Ireland.
CE Marking for 10-Plex STI Array, Quickly and efficiently testing for multiple STIs, which often have mild symptoms if any at all, ensures early diagnosis at a stage when treatment is most successful, supports the targeted use of antibiotics, and ultimately reduces their mishandling
Randox unveils SARS-CoV-2 antibody test to determine previous COVID-19 infection
Randox launch new SARS-CoV-2 IgG test, utilising patented Randox Biochip Technology to simultaneously detect IgG antibodies that are reactive to both of the leading COVID-19 diagnostic antigens – Spike Receptor Binding Domain (RBD) and Nucleocapsid protein (NP) , and superior to other commercially available COVID-19 IgG tests.
Covid Travel Testing
Randox launch travel testing service at key airport locations across the UK and Ireland, offering rapid PCR tests for those who require a negative test before travelling. The service delivers test results within 48 hours of sample receipt, to provide passengers with a cost-effective, fast and reliable COVID-19 testing service prior to their travels.
New 39-minute COVID test is now available on the Vivalytic
Point of care platforms brought to the market by Randox Laboratories and Bosch Healthcare Solutions, deliver one of the worlds fastest CE marked PCR based SARS-CoV-2 results, in just 39 minutes. With pooling cartridges available to offer simultaneous detection of multiple patient samples on one single cartridge.
Mobile COVID-19 Labs
Randox launch Mobile COVID-19 Labs for workplace testing. The service offers rapid and reliable COVID-19 testing to workplaces with capability to process up to 1000 samples per day.
Randox extends Grand National Festival Sponsorship for a further five years
Randox secured an agreement with The Jockey Club for a five-year extension to the sponsorship of the world’s greatest steeplechase, The Grand National, and the three-day Grand National Festival staged at Aintree Racecourse.
The Randox VeraSTAT launched
A new addition as of 2021, the VeraSTAT offers a simple, accurate, fast and portable point of care device based on cathodic electrochemiluminescence technology. Designed to offer users the next generation of rapid diagnosis, providing results in as little as 6 minutes.
Introducing the new VeraSTAT-V
Another new addition in 2021, the Randox VeraSTAT-V has been designed to detect the earliest signs of inflammation in veterinary diagnosis. Building upon the fond attachment Randox has with the equestrian world through the sponsorship of the Aintree Grand National, the VeraSTAT-V is a stable-side device designed to detect, measure, and monitor inflammation in whole horse blood.
Randox sign principal partnership with Sheffield United FC
Randox announce the signing of a three-year principle partnership agreement with Sheffield United. Commencing in the 2021/22 season, the deal includes both men’s and women’s first teams, with both wearing the Randox logo on their jerseys.
Gold standard testing for Team GB
Randox sign a two-year partnership with Team GB, providing Covid-19 testing for the summer and winter games. Including Tokyo 2020 and Beijing 2022.
The newly named Randox Health Academy
Randox and Sheffield United further strengthen their partnership to include naming rights of Sheffield United’s Academy. With almost 40 years of experience in the manufacture of world-leading medical diagnostics and sports science services, Randox is well positioned to assist in the development of the health, wellbeing, and performance of the next generation of male and female players.
A slam-dunking new partnership between Randox Laboratories and Olimpia Milano
Randox announced as the Official Diagnostics Partner of Olimpia Milano basketball team. The deal provides the sporting institution access to Randox’s technology to perform a variety of health testing on Olimpia’s athletes and wider support staff.
Randox design SARS-CoV-2 RBD & NP array
The Randox CE marked SARS-CoV-2 IgG RBD & NP array utilises patented biochip technology to simultaneously detect IgG antibodies against both leading COVID-19 diagnostic antigens; Spike Receptor Binding Domain (RBD) and Nucleocapsid protein (NP). The SARS-CoV-2 IgG (RBD & NP) array is compatible with both capillary and venous blood collection.
Randox develop SARS-CoV-2 Neutralising Assays
The Randox CE marked Sars-CoV-2 neutralising assays measures neutralising antibodies to Wild Type (Wuhan), Delta & Omicron variants following vaccination or natural infection. Wild Type Surrogate Virus Neutralisation Assay and Delta SARS-CoV-2 Surrogate Virus Neutralisation Assay detect antibodies that block interaction of the spike protein receptor-binding domain (RBD) and angiotensin-converting enzyme 2 (ACE2). Randox Laboratories currently have in development an assay designed to detect antibodies against SARS-CoV-2 Omicron variant.
Randox announce Variants of Concern Panel
The Randox CE marked SARS-CoV-2 IgG RBD & NP array utilises patented biochip technology to simultaneously detect IgG antibodies against both leading COVID-19 diagnostic antigens; Spike Receptor Binding Domain (RBD) and Nucleocapsid protein (NP). The SARS-CoV-2 IgG (RBD & NP) array is compatible with both capillary and venous blood collection.
Randox announced as Official Supplier of UAE Team Emirates
The agreement between Randox and the two time Tour de France winners will see Team UAE utilise the Vivalytic, a point of care platform brought to the market by Randox Laboratories and Bosch Healthcare Solutions. Testing team riders and wider support staff for COVID prior to upcoming races and tours.
Randox to deliver £10m investment for major UK research project with our future health
Randox has been announced as one of four new industry partners in the Our Future Health (OFH) programme, which will be the UK’s largest ever health research programme. Randox will deliver a £10m investment in the programme, which will discover and develop new methods of prevention, early detection and treatment of diseases and health conditions.
Randox collaborate with Verv Technologies to improve health for all
Randox Laboratories are the lead investor for Verv Technologies, who are focused on creating the first of its kind consumer-oriented, affordable, high-quality blood chemistry analyser with disposable tests for home use, that will help individuals measure a wide range of analytes (i.e., cholesterol, vitamin levels, hormones). With over 40 years of diagnostic experience, Randox Laboratories are focused on investment into technologies to improve health for all.
Randox Health expands across the UK & Republic of Ireland
Canary Wharf is the latest in a national roll-out programme of 20 Randox Health clinics, with many more planned, bringing the world’s most advanced and personalised Health Programme directly to the consumer.
Randox Laboratories and Roquefort Therapeutics Collaborate to Develop Midkine Cancer Antibodies
Randox Laboratories collaborate with Roquefort Therapeutics, an LSE market listed biotech company, dedicated to developing first in class medicines in the high value, high growth oncology market. The partnership is focused on the field of medical diagnostics only, in relation to Roquefort’s Midkine antibody portfolio.
Randox Health partners with Reviv to expand
This partnership with REVIV, who championed commercialised IV therapy, will allow people to see real-time results from taking steps to protect their health and to experience the future of wellness.
This acquisition expands Randox’s technical capabilities into the benchtop flow cytometry space aligning with their commitment to personalised medicine and improved preventative healthcare.
Team GB Official Health Diagnostics partner
The British Olympic Association (BOA) revealed that Randox Health will serve as the Official Diagnostic Health Partner for Team GB leading up to the Paris 2024 Olympic Games. Building on the triumph of their prior collaboration, during which Randox offered Covid-19 testing services for both the Tokyo 2020 and Beijing 2022 Olympics, this fresh partnership aims to revolutionise the nation’s perspective on health.
